Gilead Sciences reported $6.84B in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acorda Therapeutics ACOR:US $ 36.17M 9.55M
Agios Pharmaceuticals AGIO:US $ 400.22M 568.9M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
ALKERMES ALKS:US $ 310.44M 52.1M
Alnylam Pharmaceuticals ALNY:US $ 1093.99M 348.22M
Amgen AMGN:US $ 11969M 5339M
Arena Pharmaceuticals ARNA:US $ 386.65M 127.52M
Biogen BIIB:US $ 1541.8M 200.2M
Biomarin Pharmaceutical BMRN:US $ 617.14M 24.39M
Bluebird Bio BLUE:US $ 402.46M 48.99M
Bristol Myers Squibb BMY:US $ 13540M 2516M
Coherus Biosciences CHRS:US $ 360.54M 30.8M
Eli Lilly And LLY:US $ 3788.2M 568.2M
Gilead Sciences GILD:US $ 6837M 1944M
Glaxosmithkline GSK:US $ 3453M 50M
GlaxoSmithKline GSK:LN 3453M 50M
Intercept Pharmaceuticals ICPT:US $ 428.77M 283.15M
Moderna Inc MRNA:US 5.55B 53M
Neurocrine Biosciences NBIX:US $ 311.1M 56.9M
Novartis NOVN:VX SF 7211M 2094M
Ptc Therapeutics PTCT:US $ 189.82M 12.47M
Puma Biotechnology PBYI:US $ 63.95M 25.9M
Regeneron Pharmaceuticals REGN:US $ 3432.4M 1360.2M
Sangamo Biosciences SGMO:US $ 176.95M 7.08M
Sarepta Therapeutics SRPT:US $ 1599.11M 98.16M
Teva Pharmaceutical Industries TEVA:US $ 2045M 391M
United Therapeutics UTHR:US $ 908.5M 33.7M
Vertex Pharmaceuticals VRTX:US $ 6275.7M 212.02M
YTE INCY:US $ 1999.02M 201.44M